Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1.57 Million - $1.95 Million
7,000 Added 233.33%
10,000 $2.76 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $1.13 Million - $1.39 Million
-5,100 Reduced 62.96%
3,000 $693,000
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $920,805 - $1.19 Million
5,100 Added 170.0%
8,100 $1.86 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $665,346 - $880,413
-5,100 Reduced 62.96%
3,000 $507,000
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $2.76 Million - $3.42 Million
-25,800 Reduced 76.11%
8,100 $1.07 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $4.79 Million - $5.22 Million
-44,900 Reduced 56.98%
33,900 $3.79 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $6.54 Million - $7.63 Million
59,000 Added 297.98%
78,800 $8.73 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $289,406 - $340,652
-2,600 Reduced 11.61%
19,800 $2.57 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $6.14 Million - $7.67 Million
-71,500 Reduced 76.14%
22,400 $2.4 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $4.78 Million - $5.48 Million
63,100 Added 204.87%
93,900 $8.01 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $1.1 Million - $1.3 Million
14,800 Added 92.5%
30,800 $2.38 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $704,684 - $755,854
-8,600 Reduced 34.96%
16,000 $1.35 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $1.9 Million - $2.1 Million
24,600
24,600 $2.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.